Neurocrine Biosciences’ experimental drug, NBI-1117568, demonstrated positive results in a Phase 2 clinical trial for schizophrenia, showing a significant reduction in symptoms compared to placebo. The drug’s potential as a safer alternative to atypical antipsychotics has sparked optimism among analysts, leading to an upgrade in the company’s stock.
Two separate incidents in India, one in Bihar and the other in Uttar Pradesh, have resulted in several children and adults falling ill. In Bihar, 31 children were hospitalized after consuming filarial medicine administered during a school health campaign. Meanwhile, over 120 individuals in Uttar Pradesh were hospitalized due to food poisoning after consuming buckwheat flour during Janmashtami festivities. Authorities are investigating both incidents.
Johnson & Johnson has submitted a Biologics License Application (BLA) to the FDA seeking approval for nipocalimab, an investigational treatment for generalized myasthenia gravis (gMG). This would mark the first FDA approval for nipocalimab globally. The application is based on positive results from the Phase 3 Vivacity-MG3 study, which showed that nipocalimab plus standard of care was superior to placebo plus standard of care in a broad population of antibody-positive gMG patients.
Gain Therapeutics, Inc. (GANX) has announced positive results from its Phase 1 study for GT-02287, a potential treatment for Parkinson’s disease. The study found the drug to be safe and well-tolerated in healthy volunteers, with evidence of target engagement in the brain. The company is now planning to start a Phase 2 trial in Parkinson’s patients by the end of 2024.
Merck & Co Inc has discontinued two Phase 3 trials evaluating Keytruda (pembrolizumab) for the treatment of non-small cell lung cancer and cutaneous squamous cell carcinoma. The decision was based on recommendations from independent Data Monitoring Committees, which found that Keytruda did not demonstrate a statistically significant improvement in survival or recurrence-free survival compared to placebo.
This article delves into the fertility struggles faced by several Hollywood celebrities, highlighting their personal journeys with IVF, miscarriage, and other complications. It also emphasizes the importance of nutrition for fertility, with insights from a leading gastroenterologist on how dietary factors can impact a woman’s ability to conceive.
A rare but potentially deadly mosquito-borne virus, Eastern Equine Encephalitis (EEE), has resurfaced in the United States, causing concern among health authorities. The recent death of a healthy individual in New Hampshire marks the state’s first human case in a decade and highlights the growing threat of EEE across the country. This article explores the characteristics of the virus, its symptoms, the current outbreak, and prevention measures.
Discover the remarkable changes that occur when you stop drinking alcohol, from improved sleep and mental clarity to enhanced skin, relationships, and overall well-being. Learn about the timeline of benefits, tips for success, and the importance of seeking professional support when needed.
A new study presented at the ESC Congress 2024 suggests that getting extra sleep on weekends can significantly reduce the risk of developing heart disease, especially for those who regularly experience sleep deprivation during the week. Researchers found that individuals who made up for lost sleep had a 19% lower chance of developing heart problems, and for those consistently sleep-deprived, the risk reduction was even more pronounced at 20%.
Popular influencer Vanessa Lopes has revealed that her recent acne breakouts were caused by an iron deficiency. After undergoing medical tests, Lopes discovered her iron levels were below the ideal range. This revelation highlights the importance of maintaining balanced iron levels for overall health and skin health.
